AKR1B1L
| Species | Cat.# | Product name | Source (Host) | Tag | Protein Length | Price |
|---|---|---|---|---|---|---|
| Chicken | AKR1B1L-4515C | Recombinant Chicken AKR1B1L | Mammalian Cell | His |
|
- Involved Pathway
- Protein Function
- Interacting Protein
AKR1B1L involved in several pathways and played different roles in them. We selected most pathways AKR1B1L participated on our site, such as Pentose and glucuronate interconversions, Fructose and mannose metabolism, Galactose metabolism, which may be useful for your reference. Also, other proteins which involved in the same pathway with AKR1B1L were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|---|
| Pentose and glucuronate interconversions | UGT2B7;DHDH;AKR1B8;AKR1B7;XYLB;AKR1B1;ALDH1B1;UGT1A4;KL |
| Fructose and mannose metabolism | ENOSF1;TPI1;KHK;PFKFB4L;PFKL;AKR1B10;HK3;TIGARA;FBP1 |
| Galactose metabolism | PGM2;HKDC1;HK2;AKR1B1L;PFKM;AKR1B8;G6PCA.1;GANC;AKR1B1 |
| Glycerolipid metabolism | LCLAT1;LPL;AGPAT6;PNLIPRP2;PPAP2C;LPIN2;GLA;MBOAT2;MOGAT1 |
| Metabolic pathways | ALG11;FUT9A;ASPA;PFKP;NDUFB2;GMDS;ALPI.2;DNMT3AB;INPP1 |
AKR1B1L has several biochemical functions, for example, . Some of the functions are cooperated with other proteins, some of the functions could acted by AKR1B1L itself. We selected most functions AKR1B1L had, and list some proteins which have the same functions with AKR1B1L. You can find most of the proteins on our site.
| Function | Related Protein |
|---|
AKR1B1L has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with AKR1B1L here. Most of them are supplied by our site. Hope this information will be useful for your research of AKR1B1L.
- Q&As
- Reviews
Q&As (16)
Ask a questionThe efficacy of AKR1B1L in the treatment of ocular diseases needs to be confirmed by further clinical studies.
Further clinical studies are needed to confirm the persistence of the therapeutic effect of recombinant AKR1B1L.
The efficacy and safety of recombinant AKR1B1L need to be further studied and confirmed, and it is not widely used in clinical therapy.
The efficacy of AKR1B1L needs to be further confirmed by clinical trials.
Currently, recombinant AKR1B1L has not been approved by the FDA for clinical use.
The effects of recombinant AKR1B1L versus other treatments still need to be studied and compared in clinical trials.
Recombinant AKR1B1L may have some side effects, such as nausea, diarrhea, headache, and allergic reactions may occur in some patients.
At present, the results of clinical trials on recombinant AKR1B1L are different, and some studies have shown that it has certain clinical effects in diabetes, ophthalmology and other fields, but it is not widely recognized.
Recombinant AKR1B1L can be used as a potential therapeutic target for cardiovascular disease, but further clinical studies are needed to confirm its efficacy and safety.
Recombinant AKR1B1L can effectively reduce the metabolites of glucose, so as to prevent or delay the damage of the eyes, kidneys, nerves and other organs caused by diabetes.
Compared with traditional treatment methods, recombinant AKR1B1L has a more specific target and can effectively reduce glucose metabolites, thereby preventing or delaying organ damage caused by diseases such as diabetes.
Recombinant AKR1B1L is usually administered by injection.
The safety of recombinant AKR1B1L has certain risks, such as the possibility of some side effects and allergic reactions in individual patients.
The dosage of recombinant AKR1B1L needs to be adjusted individually according to the specific situation of the patient, and is generally determined by the doctor according to the comprehensive consideration of the patient's physical condition and clinical manifestations.
Recombinant AKR1B1L is a synthetic enzyme prepared by genetic engineering technology that converts glucose into sorbitol.
Recombinant AKR1B1L is mainly used in the treatment of diabetes, eye diseases and cardiovascular diseases.
Customer Reviews (4)
Write a reviewAKR1B1L has good DNA binding ability and performs well in related experiments.
AKR1B1L has made significant research progress in the application of related fields.
Low immunogenicity and does not cause abnormal immune responses.
The structural integrity of AKR1B1L was verified, and the folding state and secondary structure were consistent with the native protein.
Ask a Question for All AKR1B1L Products
Required fields are marked with *
My Review for All AKR1B1L Products
Required fields are marked with *
